Literature DB >> 9699086

Infections in patients with type 2 diabetes in general practice.

M L Bartelink1, L Hoek, J P Freriks, G E Rutten.   

Abstract

BACKGROUND: The association between diabetes, glycaemic control and the prevalence of infections seems obvious to most general practitioners. However, this association is still not very clear. AIM: The aim of this study in general practice was to investigate which infections patients with treated type 2 diabetes present to their general practitioner, and to study whether a relationship exists between glycaemic status and these infections.
METHOD: Over a period of 2 years eight fasting glucose and glycosylated haemoglobin values were related to the presented infections in 328 patients.
RESULTS: 193 patients presented with one or more infections (a total of 458 infections, with a mean of 2.4 (+/- 1.9) infections). Patients with and without infections did not differ in mean glycosylated haemoglobin and fasting glucose levels. There was no difference in presentation of infections between well controlled and less controlled patients. However, patients who presented with an infection showed significantly higher mean glycosylated haemoglobin levels in that period compared to the mean levels in periods without any infection.
CONCLUSION: Considering the limitations of this study, hyperglycaemia is more likely a result of than a cause of common infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699086     DOI: 10.1016/s0168-8227(98)00023-0

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Prediction of complicated urinary tract infections in patients with type 2 diabetes: a questionnaire study in primary care.

Authors:  Leonie M A J Venmans; Marian Sloof; Eelko Hak; Kees J Gorter; Guy E H M Rutten
Journal:  Eur J Epidemiol       Date:  2007-01-03       Impact factor: 8.082

2.  Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.

Authors:  Kenneth Berman; Sweta Tandra; Kate Forssell; Raj Vuppalanchi; Raj Vuppalanch; James R Burton; James Nguyen; Devonne Mullis; Paul Kwo; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2010-11-17       Impact factor: 11.382

3.  Stress Hyperglycemia and Mortality in Subjects With Diabetes and Sepsis.

Authors:  Andrea Fabbri; Giulio Marchesini; Barbara Benazzi; Alice Morelli; Danilo Montesi; Cesare Bini; Stefano Giovanni Rizzo
Journal:  Crit Care Explor       Date:  2020-07-15

4.  Diabetes mellitus and odontogenic infections--an exaggerated risk?

Authors:  Mohan Alexander; B Krishnan; Nithin Shenoy
Journal:  Oral Maxillofac Surg       Date:  2008-09

5.  Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp.

Authors:  Santi M Mandal; Denial Mahata; Ludovico Migliolo; Aditya Parekh; Partha S Addy; Mahitosh Mandal; Amit Basak
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

6.  Trends, productivity losses, and associated medical conditions among toxoplasmosis deaths in the United States, 2000-2010.

Authors:  Patricia L Cummings; Tony Kuo; Marjan Javanbakht; Frank Sorvillo
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

7.  The prevalence of giardia intestinalis in dyspeptic and diabetic patients.

Authors:  Gözde Derviş Hakim; Safak Kızıltaş; Hilmi Ciftçi; Safak Göktaş; Ilyas Tuncer
Journal:  ISRN Gastroenterol       Date:  2011-07-27

8.  Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients.

Authors:  Peihong Yin; Jianbo Li; Qiong Wen; Yagui Qiu; Wenyi Liang; Junxian Wang; Jing Yu; Zhong Zhong; Xiao Yang; Xueqing Yu; Qing Ye; Fengxian Huang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 9.  SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Authors:  Caio Henrique Mazucanti; Josephine Mary Egan
Journal:  Immun Ageing       Date:  2020-06-30       Impact factor: 6.400

10.  Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study.

Authors:  Chia-Hsuin Chang; Jiun-Ling Wang; Li-Chiu Wu; Lee-Ming Chuang; Hsien-Ho Lin
Journal:  Open Forum Infect Dis       Date:  2019-08-16       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.